We are live on
!
Find out more
Lazard Asset Management Portfolio holdings
AUM
$60.8B
1-Year Est. Return
22.47%
This Fund
S&P 500
This Quarter
Est. Return
+14.09%
1 Year Est. Return
+22.47%
3 Year Est. Return
+62.53%
5 Year Est. Return
+77.87%
10 Year Est. Return
+305.76%
AUM
$79.1B
AUM Growth
+$7.99B
(+11%)
Cap. Flow
-$5.86B
Cap. Flow
% of AUM
-7.4%
Top 10 Holdings %
Top 10 Hldgs %
22.63%
Holding
2,061
New
445
Increased
504
Reduced
465
Closed
231
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Sysco
SYY
|
+$273M |
| 2 |
Waste Management
WM
|
+$168M |
| 3 |
Lowe's Companies
LOW
|
+$160M |
| 4 |
PNC Financial Services
PNC
|
+$154M |
| 5 |
Unilever
UL
|
+$122M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$548M |
| 2 |
Apple
AAPL
|
+$372M |
| 3 |
CSX Corp
CSX
|
+$369M |
| 4 |
Infosys
INFY
|
+$238M |
| 5 |
Kimberly-Clark
KMB
|
+$235M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.16% |
| 2 | Healthcare | 14.65% |
| 3 | Financials | 13.08% |
| 4 | Industrials | 9.66% |
| 5 | Consumer Discretionary | 9.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
DBD
1026
DELISTED
Diebold Nixdorf Incorporated
DBD
| $106K | ﹤0.01% |
10,000
| – | – |
|
|
AJRD
1027
DELISTED
Aerojet Rocketdyne Holdings
AJRD
| $105K | ﹤0.01% |
2,001
-60,287
| -97% | -$2.42M |
|
1028
CarGurus
CARG
$3.52B
| $104K | ﹤0.01% |
3,284
-1,642
| -33% | -$40.6K |
|
|
SNBR
1029
DELISTED
Sleep Number
SNBR
| $103K | ﹤0.01% |
1,261
| – | – |
|
1030
Modine Manufacturing
MOD
$10.4B
| $102K | ﹤0.01% |
+8,153
| New | +$79.1K |
|
1031
Ultragenyx Pharmaceutical
RARE
$2.55B
| $102K | ﹤0.01% |
743
+16
| +2% | +$1.9K |
|
1032
United Rentals
URI
$72.4B
| $102K | ﹤0.01% |
441
+15
| +4% | +$3.17K |
|
|
VIVO
1033
DELISTED
Meridian Bioscience Inc
VIVO
| $100K | ﹤0.01% |
5,357
-48
| -0.9% | -$896 |
|
1034
eGain
EGAN
$201M
| $99K | ﹤0.01% |
8,391
| – | – |
|
1035
Establishment Labs
ESTA
$2.28B
| $99K | ﹤0.01% |
2,633
+427
| +19% | +$11.3K |
|
1036
America's Car Mart
CRMT
$26.9M
| $98K | ﹤0.01% |
+895
| New | +$90.1K |
|
1037
Deluxe
DLX
$1.15B
| $98K | ﹤0.01% |
+3,358
| New | +$86.6K |
|
1038
Quanex
NX
$1.01B
| $98K | ﹤0.01% |
4,433
+3,763
| +562% | +$77.5K |
|
|
SPNS
1039
DELISTED
Sapiens International
SPNS
| $98K | ﹤0.01% |
3,230
-740
| -19% | -$21.7K |
|
1040
Travere Therapeutics
TVTX
$5.78B
| $98K | ﹤0.01% |
3,616
| – | – |
|
1041
ePlus
PLUS
$2.34B
| $97K | ﹤0.01% |
2,220
-454
| -17% | -$18.2K |
|
1042
Anika Therapeutics
ANIK
$287M
| $96K | ﹤0.01% |
2,122
-36
| -2% | -$1.37K |
|
1043
CRA International
CRAI
$1.09B
| $96K | ﹤0.01% |
+1,902
| New | +$85.5K |
|
1044
Global Industrial
GIC
$1.49B
| $96K | ﹤0.01% |
+2,693
| New | +$80.3K |
|
|
SCS
1045
DELISTED
Steelcase
SCS
| $96K | ﹤0.01% |
7,143
+4,151
| +139% | +$50.8K |
|
1046
VF Corp
VFC
$5.89B
| $96K | ﹤0.01% |
1,128
+408
| +57% | +$32.6K |
|
|
EGIO
1047
DELISTED
Edgio, Inc. Common Stock
EGIO
| $96K | ﹤0.01% |
+603
| New | +$110K |
|
1048
Gen Digital
GEN
$17.5B
| $95K | ﹤0.01% |
4,605
-2,026
| -31% | -$40.9K |
|
1049
Arbor Realty Trust
ABR
$998M
| $94K | ﹤0.01% |
+6,691
| New | +$86.8K |
|
1050
Murphy USA
MUSA
$9.61B
| $94K | ﹤0.01% |
719
| – | – |
|
Similar funds
QCM
Lazard Asset Management's Q4 2020 Portfolio in Review
As of Q4 2020, Lazard Asset Management held 2,061 positions worth $79.1B, up 11% from $71.1B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Lazard Asset Management withdrew a net $5.86B in Q4 2020, closing 231 positions and reducing 465 holdings. Its most notable exit was Unilever NV New York Registry Shares, an estimated $112M position sold in full.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 21% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Lazard Asset Management opened a new position in Sotera Health worth $100M.
- Lazard Asset Management's largest Q4 2020 buy was Sotera Health: 3,651,831 shares worth $100M.
- Lazard Asset Management added most to Sysco in Q4 2020, an estimated $273M increase.
- Lazard Asset Management's biggest Q4 2020 reduction was Pfizer, cutting an estimated $548M.
- Lazard Asset Management fully exited Unilever NV New York Registry Shares in Q4 2020, selling an estimated $112M.
- Lazard Asset Management's ten largest holdings make up 23% of its $79.1B portfolio in Q4 2020.
- Lazard Asset Management opened 445 new positions and closed 231 in Q4 2020.
- Lazard Asset Management's portfolio value rose 11% quarter-over-quarter to $79.1B.
Based on Lazard Asset Management's 13F filing for Q4 2020, filed 11 Feb 2021.